TY - JOUR
T1 - Implications of maximal muscle strength and aerobic capacity for lower extremity physical function in people with multiple sclerosis
T2 - a cross-sectional study
AU - Taul-Madsen, Laurits
AU - Dalgas, Ulrik
AU - Riis, Hjalte
AU - Broløs, Magnus K.
AU - Lundbye-Jensen, Jesper
AU - Hvid, Lars G.
N1 - Publisher Copyright:
© The Author(s), 2025.
PY - 2025
Y1 - 2025
N2 - Background: Multiple sclerosis (MS) is characterized by impairment of physical function that is often linked to neuromuscular and cardiovascular deficits. However, the specific contributions of muscle strength and aerobic capacity to physical function in MS are not fully understood. Objective: This study aimed to investigate the independent roles of maximal muscle strength (MVC) and aerobic capacity (VO2peak) on lower extremity physical function, as measured by the 6-minute walk test (6MWT) and five-time sit-to-stand test (5STS) in people with MS (pwMS). Methods: In a cross-sectional study, 150 pwMS underwent assessment of VO2peak, maximal voluntary contraction (MVC), and physical function (6MWT and 5STS). Regression analyses were conducted to explore the associations between physiological parameters and physical function. Results: MVC and VO2peak were moderately associated with (i.e., explained) 6MWT (R² = 0.40, p < 0.001), yet with VO2peak (β = 7.9, std. β = 0.45, p < 0.001) having a preferential influence compared to MVC (β = 48.2, std. β = 0.26, p < 0.001). MVC and VO2peak were weakly associated with (i.e., explained) 5STS (R² = 0.14, p < 0.001), yet with MVC (β = 0.06, std. β = 0.28, p = 0.004) having a preferential influence compared to VO2peak (β = 0.00, std. β = 0.16, p = 0.101). Conclusion: Both maximal muscle strength and aerobic capacity to physical function in pwMS. Maximal muscle strength was preferentially linked to performance in the 5STS test, whereas aerobic capacity was preferentially linked to performance in the 6MWT. These findings support the need for tailored exercise interventions to target specific physiological deficits during MS rehabilitation.
AB - Background: Multiple sclerosis (MS) is characterized by impairment of physical function that is often linked to neuromuscular and cardiovascular deficits. However, the specific contributions of muscle strength and aerobic capacity to physical function in MS are not fully understood. Objective: This study aimed to investigate the independent roles of maximal muscle strength (MVC) and aerobic capacity (VO2peak) on lower extremity physical function, as measured by the 6-minute walk test (6MWT) and five-time sit-to-stand test (5STS) in people with MS (pwMS). Methods: In a cross-sectional study, 150 pwMS underwent assessment of VO2peak, maximal voluntary contraction (MVC), and physical function (6MWT and 5STS). Regression analyses were conducted to explore the associations between physiological parameters and physical function. Results: MVC and VO2peak were moderately associated with (i.e., explained) 6MWT (R² = 0.40, p < 0.001), yet with VO2peak (β = 7.9, std. β = 0.45, p < 0.001) having a preferential influence compared to MVC (β = 48.2, std. β = 0.26, p < 0.001). MVC and VO2peak were weakly associated with (i.e., explained) 5STS (R² = 0.14, p < 0.001), yet with MVC (β = 0.06, std. β = 0.28, p = 0.004) having a preferential influence compared to VO2peak (β = 0.00, std. β = 0.16, p = 0.101). Conclusion: Both maximal muscle strength and aerobic capacity to physical function in pwMS. Maximal muscle strength was preferentially linked to performance in the 5STS test, whereas aerobic capacity was preferentially linked to performance in the 6MWT. These findings support the need for tailored exercise interventions to target specific physiological deficits during MS rehabilitation.
KW - aerobic capacity
KW - exercise
KW - maximal muscle strength
KW - Physical function
KW - rehabilitation
KW - walking
U2 - 10.1177/20552173251326171
DO - 10.1177/20552173251326171
M3 - Journal article
C2 - 40125490
AN - SCOPUS:105000669586
VL - 11
JO - Multiple Sclerosis Journal - Experimental, Translational and Clinical
JF - Multiple Sclerosis Journal - Experimental, Translational and Clinical
IS - 1
ER -